Genomic sequencing puts Hong Kong at forefront of cancer care innovation

Genomic sequencing has helped Hong Kong identify the right treatments for cancer patients more quickly, according to an expert who also suggested that the city could be a “super-linker” between mainland China and the rest of the world in drug development. Aya El Helali, a clinician-scientist in medical oncology at the University of Hong Kong, praised how collaboration within the Greater Bay Area had opened up opportunities to run clinical trials faster and at lower costs – factors that appealed...